Trojan horses for drugs: a new role for lipoproteins?

Curr Opin Lipidol. 2016 Dec;27(6):638-639. doi: 10.1097/MOL.0000000000000362.

Authors

Giuseppe Ciccarella¹, Gertrud Lund, Silvio Zaina

Affiliation

¹ aDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce bIstituto di Nanotecnologia CNR-Nanotec, Lecce, Italy cDepartment of Genetic Engineering, CINVESTAV Irapuato Unit, Irapuato dDepartment of Medical Sciences, Division of Health Sciences, Leon Campus, University of Guanajuato, Leon, Guanajuato, Mexico.

PMID: 27805976
DOI: 10.1097/MOL.0000000000000362

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cardiovascular Diseases / prevention & control
Docosahexaenoic Acids / administration & dosage
Docosahexaenoic Acids / chemistry
Humans
Lipoproteins* / administration & dosage
Lipoproteins* / chemistry
Nanoparticles* / administration & dosage

Substances

Lipoproteins
Docosahexaenoic Acids